GrrlScientist is an evolutionary biologist, ornithologist, aviculturist, birder and freelance science and nature writer. A native of the Pacific Northwest, she relocated from Seattle to NYC with her parrots after earning a BS in Microbiology (emphasis in Virology) and PhD in Zoology (Ornithology) from the University of Washington. In NYC, she was the Chapman Postdoctoral Fellow at the American Museum of Natural History for two years, pursuing part of her "dream" research project by reconstructing a molecular phylogeny of the parrots of the South Pacific islands. GrrlScientist and her five parrots are currently relocating to Germany, where she will continue writing her blog while also writing a book and learning German. (Meanwhile, her parrots will continue to nibble on her extensive personal library.) If you appreciate GrrlScientist's writing, you can help pay her living expenses by hiring her to "blog" your conference, speak at your club or write articles for your publication (or by clicking on the Paypal button below). If you read an essay on this blog that you especially enjoyed, please nominate it for inclusion in 
Relying on bacterial enzymes, scientists have developed a way of converting blood from groups A, B and AB into group O, which can be safely transfused into any patient. The blood cells from groups A and B have one of two different sugar molecules -- known as antigens -- on their surface, which can trigger a powerful, and potentially deadly, immune response. AB blood has both types of antigens, while group O blood has neither.
Groups A, B and AB can only be transfused into patients with compatible blood types, while type O, rhesus negative, can be given to anyone.
After a search of 2,500 fungi and bacteria the researchers discovered two bacteria -- Elizabethkingia meningosepticum and Bacterioides fragilis -- contained potentially useful enzymes. The team found that enzymes from both bacteria were able to remove both A and B antigens from red blood cells, effectively converting them to type O blood.
Writing in the same journal, blood experts Geoff Daniels, of the Bristol Institute for Transfusion Sciences, and Stephen Withers, of the University of British Columbia, Canada, welcome the research.
They said the use of enzymes to convert blood group has long been proposed, but has proved to be impractical due to the inefficiency and incompatibility of available enzymes.
They said the use of enzymes to convert blood group has long been proposed, but has proved to be impractical due to the inefficiency and incompatibility of available enzymes.
Unfortunately, these enzymes are ineffective against another antigen that is found on the surface of red blood cells. This antigen is known as the rhesus type. The presence of the rhesus antigen on human blood cells is referred to rhesus positive, or "rh positive", while its absence is denoted as "rh negative".
This research, spearheaded by the University of Copenhagen, is reported in the journal Nature Biotechnology.
Cited story.
.
Comments
Very cool, this is a major advance! And I'm sure an Rh antigen-washer will be found in due course.
Posted by: David Harmon | April 4, 2007 12:32 PM